BioMarin posts first $1 billion quarter, sets VOXZOGO PDUFA date for hypochondroplasiaNov 2Quarterly updateBiomarin Pharmaceutical Incvosoritide
Travere Therapeutics names Bradley Campbell CEO as Eric Dube exitsSep 21PeopleTravere Therapeutics, Inc.
Amicus reports FY2025 results as BioMarin merger deal proceedsJul 13PeopleBiomarin Pharmaceutical Inc